company background image
MIR logo

MedMira TSXV:MIR Stock Report

Last Price

CA$0.14

Market Cap

CA$91.2m

7D

3.8%

1Y

42.1%

Updated

31 Jan, 2025

Data

Company Financials

MedMira Inc.

TSXV:MIR Stock Report

Market Cap: CA$91.2m

MIR Stock Overview

A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. More details

MIR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Earnings have declined by 19.2% per year over past 5 years

Has less than 1 year of cash runway

Negative shareholders equity

Makes less than USD$1m in revenue (CA$356K)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

MedMira Inc. Competitors

Theralase Technologies

TSXV:TLT

CA$68.1m

Therma Bright

TSXV:THRM

CA$15.8m

Profound Medical

TSX:PRN

CA$279.9m

Aurora Spine

TSXV:ASG

CA$34.1m

Price History & Performance

Summary of share price highs, lows and changes for MedMira
Historical stock prices
Current Share PriceCA$0.14
52 Week HighCA$0.14
52 Week LowCA$0.07
Beta10.3
1 Month Change42.11%
3 Month Change68.75%
1 Year Change42.11%
3 Year Change-18.18%
5 Year Change440.00%
Change since IPO-98.71%

Recent News & Updates

Recent updates

We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Jan 29
We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Here's What We Think About MedMira's (CVE:MIR) CEO Pay

Jan 20
Here's What We Think About MedMira's (CVE:MIR) CEO Pay

Shareholder Returns

MIRCA Medical EquipmentCA Market
7D3.8%-2.4%-0.5%
1Y42.1%-16.0%17.7%

Return vs Industry: MIR exceeded the Canadian Medical Equipment industry which returned -17.9% over the past year.

Return vs Market: MIR exceeded the Canadian Market which returned 17.9% over the past year.

Price Volatility

Is MIR's price volatile compared to industry and market?
MIR volatility
MIR Average Weekly Movement13.5%
Medical Equipment Industry Average Movement13.8%
Market Average Movement8.4%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market2.9%

Stable Share Price: MIR's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: MIR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
1993n/aHermes Chanmedmira.com

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and REVEALCOVID-19 and Reveal G4 HIV tests.

MedMira Inc. Fundamentals Summary

How do MedMira's earnings and revenue compare to its market cap?
MIR fundamental statistics
Market capCA$91.22m
Earnings (TTM)-CA$3.85m
Revenue (TTM)CA$356.43k

265.8x

P/S Ratio

-24.6x

P/E Ratio

Is MIR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MIR income statement (TTM)
RevenueCA$356.43k
Cost of RevenueCA$1.02m
Gross Profit-CA$662.63k
Other ExpensesCA$3.18m
Earnings-CA$3.85m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0055
Gross Margin-185.91%
Net Profit Margin-1,079.18%
Debt/Equity Ratio-67.4%

How did MIR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 06:19
End of Day Share Price 2025/01/31 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedMira Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution